Page last updated: 2024-11-05

triazolam and Pulmonary Edema

triazolam has been researched along with Pulmonary Edema in 1 studies

Triazolam: A short-acting benzodiazepine used in the treatment of insomnia. Some countries temporarily withdrew triazolam from the market because of concerns about adverse reactions, mostly psychological, associated with higher dose ranges. Its use at lower doses with appropriate care and labeling has been reaffirmed by the FDA and most other countries.

Pulmonary Edema: Excessive accumulation of extravascular fluid in the lung, an indication of a serious underlying disease or disorder. Pulmonary edema prevents efficient PULMONARY GAS EXCHANGE in the PULMONARY ALVEOLI, and can be life-threatening.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chan, TH1
Ho, SS1
Li, PK1

Other Studies

1 other study available for triazolam and Pulmonary Edema

ArticleYear
Noncardiogenic pulmonary edema associated with triazolam.
    Journal of toxicology. Clinical toxicology, 1995, Volume: 33, Issue:2

    Topics: Adult; Humans; Male; Pulmonary Edema; Triazolam

1995